bso glutathione inhibitor The synthesis buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma resistant human breast cancer cells Sigma-Aldrich ᴅʟ-Buthionine-sulfoximine, CAS 5072-26-4, ≥99.0%
Sigma Aldrich Buthionine sulfoximine, CAS 5072 26 4, 99.0% (TLC) 250 mg Frontiers Systemic L Buthionine S R Sulfoximine Treatment Increases Plasma NGF and Upregulates L cys L cys2 Transporter and Glutamylcysteine Ligase mRNAs Through the NGF TrkA Akt Nrf2 Pathway in the Striatum Lowering glutathione level by buthionine sulfoximine enhances in vivo photodynamic therapy using chlorin e6 loaded nanoparticles ScienceDirect Depletion of cellular GSH by treatment with l Download Scientific Diagram Nucleotide biosynthesis links glutathione metabolism to ferroptosis sensitivity Life Science Alliance
Pay in 4 interest-free payments of $6.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




